Beatrice Leung

Beatrice’s experience includes advising:

• Existing owners EQT, CPP Investments, and Nord Anglia Education on the US$14.5 billion sale of Nord Anglia Education to a consortium formed by Neuberger Berman Private Markets, EQT, and CPP Investments, together with other global institutional investor
• BPEA EQT Funds V and VI and portfolio company Vistra (BPEA EQT) on the merger of Vistra with Tricor, an existing BPEA EQT Fund VIII portfolio company, in a transaction which values the combined company at an enterprise value of US$6.5 billion; this transaction was named Private Equity Exit of the Year (Large Cap) by The Asian Private Equity & Venture Capital Awards 2023
• Ares Management:
  • on its £755 million preferred equity investment alongside Lone Star in Wembley’s Quintain
  • on its acquisition of BlueCove Limited, the London-based scientific fixed income manager 
• Bain & Co on its acquisition of Enterprise Blueprints Limited, a UK-based IT services and consulting business
• Goldman Sachs Asset Management on its acquisition of the Clear Group, a commercial insurance broker focused on the UK corporate and SME market, from ECI Partners
• Integro, an Odyssey Investments portfolio company on its acquisition of Risk Transfer Group
• Norgine Europe B.V., a Netherlands-based specialty pharmaceutical company, in its US$2 billion sale to Goldman Sachs
• Warburg Pincus, as investor, in its US$400 million Series D fundraise and subsequent US$80 million fundraise by Advance Intelligence Group, an AI-driven technology platform
• Canva Inc. on its largest acquisition to date of Affinity, a UK-based software services provider
• Darktrace plc, a global leader in cybersecurity artificial intelligence and FTSE 250 company, on its US$5.3 billion takeover by Thoma Bravo 
• Tianqi Lithium, a leading global lithium producer, on its HK$13.5 billion (US$1.7 billion) H share initial public offering on the Main Board of The Stock Exchange of Hong Kong Limited
• The underwriters on the HK$645 million IPO and listing of Transcenta, a clinical stage global biotherapeutics company headquartered in Suzhou, China, on the Main Board of The Stock Exchange of Hong Kong
• Jinmao Property Services Co. Limited, the leading high-end property management provider in China, on its HK$825 million initial public offering on the Main Board of The Stock Exchange of Hong Kong Limited